Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma

Long-term Temozolomide Treatment Induces Marked Amino Metabolism Modifications and an Increase in TMZ Sensitivity in Hs683 Oligodendroglioma Cells

(2015) Delphine Lamoral-Theys et al.   NEOPLASIA

Chromatin Regulator PRC2 Is a Key Regulator of Epigenetic Plasticity in Glioblastoma

(2013) A. Natsume et al.   CANCER RESEARCH

N-Acetylaspartate (NAA) andN-Acetylaspartylglutamate (NAAG) Promote Growth and Inhibit Differentiation of Glioma Stem-like Cells

(2013) Patrick M. Long et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Metabolomic Signature of Malignant Glioma Reflects Accelerated Anabolic Metabolism

(2012) P. Chinnaiyan et al.   CANCER RESEARCH

DNA Methylation Does Not Stably Lock Gene Expression but Instead Serves as a Molecular Mark for Gene Silencing Memory

(2012) N. J.- M. Raynal et al.   CANCER RESEARCH

Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma Xenografts

(2012) G. J. Kitange et al.   CLINICAL CANCER RESEARCH

Phase I Study of Vorinostat in Combination with Temozolomide in Patients with High-Grade Gliomas: North American Brain Tumor Consortium Study 04-03

(2012) E. Q. Lee et al.   CLINICAL CANCER RESEARCH

Acetate supplementation modulates brain histone acetylation and decreases interleukin-1β expression in a rat model of neuroinflammation

(2012) Mahmoud L Soliman et al.   Journal of Neuroinflammation

Self-Renewal and Differentiation of Reactive Astrocyte-Derived Neural Stem/Progenitor Cells Isolated from the Cortical Peri-Infarct Area after Stroke

(2012) I. S. Shimada et al.   JOURNAL OF NEUROSCIENCE

Comparison of Intraprostatic Ethanol Diffusion Using a Microporous Hollow Fiber Catheter Versus a Standard Needle

(2012) Benjamin J. King et al.   JOURNAL OF UROLOGY

The Warburg Effect Dictates the Mechanism of Butyrate-Mediated Histone Acetylation and Cell Proliferation

(2012) Dallas R. Donohoe et al.   MOLECULAR CELL

Longitudinal Whole-BrainN-Acetylaspartate Concentration in Healthy Adults

(2011) D.J. Rigotti et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Extensive aspartoacylase expression in the rat central nervous system

(2011) John R. Moffett et al.   GLIA

The impact of molecular and clinical factors on patient outcome in oligodendroglioma from 20years’ experience at a single centre

(2011) Jonathon F. Parkinson et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Acetate supplementation increases brain histone acetylation and inhibits histone deacetylase activity and expression

(2011) Mahmoud L. Soliman et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

A safety trial of high dose glyceryl triacetate for Canavan disease

(2011) Reeval Segel et al.   MOLECULAR GENETICS AND METABOLISM

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study

(2011) B. B. Friday et al.   NEURO-ONCOLOGY

CD44v6 Regulates Growth of Brain Tumor Stem Cells Partially through the AKT-Mediated Pathway

(2011) Mayumi Jijiwa et al.   PLoS One

Suberoylanilide hydroxamic acid limits migration and invasion of glioma cells in two and three dimensional culture

(2010) Zhihua An et al.   CANCER LETTERS

Differential aminoacylase expression in neuroblastoma

(2010) Patrick M. Long et al.   INTERNATIONAL JOURNAL OF CANCER

Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells

(2010) F. Orzan et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma

(2010) Phillip Stafford et al.   Nutrition & Metabolism

Global Levels of Histone Modifications Predict Prognosis in Different Cancers

(2009) David B. Seligson et al.   AMERICAN JOURNAL OF PATHOLOGY

Arrested neural and advanced mesenchymal differentiation of glioblastoma cells-comparative study with neural progenitors

(2009) Piotr Rieske et al.   BMC CANCER

EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance

(2009) M.-L. Suva et al.   CANCER RESEARCH

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

(2009) Evanthia Galanis et al.   JOURNAL OF CLINICAL ONCOLOGY

BMI1 Sustains Human Glioblastoma Multiforme Stem Cell Renewal

(2009) M. Abdouh et al.   JOURNAL OF NEUROSCIENCE

ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation

(2009) K. E. Wellen et al.   SCIENCE

Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-Renewal

(2008) J. Godlewski et al.   CANCER RESEARCH

Mesenchymal differentiation of glioblastoma stem cells

(2008) L Ricci-Vitiani et al.   CELL DEATH AND DIFFERENTIATION

Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates myogenesis and β1 integrin expression in vitro

(2007) Gentian Lluri et al.   EXPERIMENTAL CELL RESEARCH